bgj-398 mesylate

GSK598809 is a selective D(3)R antagonist recently progressed in Phase I trials. GSK-598809 may decrease the rewarding effects of contextual cues associated with drug intake preclinically, which may reduce drug craving in humans.

GSK-598809 L-tartrate is an acute D3 antagonist.

(-)-GSK598809 hydrochloride 是 GSK598809 的异构体。GSK598809 是多巴胺 D3 受体 (DRD3) 的选择性拮抗剂，是一种选择性增强货币政策期间的神经反应药物和酒精依赖中的奖励预期，可能修复物质依赖中的奖励缺陷。

GSK-598809 L-tartrate sesquihydrate is an acute D3 antagonist.

(-)-GSK598809 is an isomer of GSK598809 that is a potent and selective antagonist of dopamine D3 Receptor.